June 16, 2010
For those of you who have come here for the first time let me inform you as to why I am writing this series. I was part of an international group of women and we had a “listening session” with the FDA and presented our findings, based on scientific, peer reviewed and FDA and CDC documents. The presentation was held on March 12th of 2010 and the silence of the FDA to our findings is deafening.
What I am going to do is inform you as to what our findings are in a series of articles. The reason for this is because the presentation had 54 slides and there is just too much data involved for just one article.
Just a quick note, I have put a definition section at the end of the article because there are items that require further explanation to be understood.
Today, I am going to answer the question “My daughter has received an irregular pap test two years after the vaccination series. I thought the vaccine was supposed to prevent this?” This is something that we are now receiving more and more reports of. Just recently we saw that there is a report on the VAERS data base that stated that a young 32 year old female vaccinated with Cervarix “was diagnosed with adenocarcinoma” (cancer). Here is the write-up from the VAERS (Vaccine Adverse Event Reporting System) report number 385637.
Write-up: This case was reported by a physician via a sales representative and described the occurrence of adenocarcinoma in a 32-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Relevant medical history includes a post natal check with normal cervix appearance and a pap smear test with normal result. Subsequently, the subject received full course of CERVARIX. On an unspecified date the subject received 1st dose, 2nd dose and 3rd dose of CERVARIX (.5 ml, unknown, lot number not provided). On 3 April 2010, within months of the last vaccination with CERVARIX, the subject experienced post coital bleeding. She was found to have papillary projectary mass on cervix with abnormal appearance. A pap smear and a biopsy were performed and she was diagnosed with adenocarcinoma. The reporting physician considered the events to be clinically significant/intervention required. At the time of reporting the outcome of the events was unspecified.